NZ513835A - Methods for using vaginal lactobacillus - Google Patents

Methods for using vaginal lactobacillus

Info

Publication number
NZ513835A
NZ513835A NZ513835A NZ51383598A NZ513835A NZ 513835 A NZ513835 A NZ 513835A NZ 513835 A NZ513835 A NZ 513835A NZ 51383598 A NZ51383598 A NZ 51383598A NZ 513835 A NZ513835 A NZ 513835A
Authority
NZ
New Zealand
Prior art keywords
methods
vaginal
disclosed
medicant
vaginal lactobacillus
Prior art date
Application number
NZ513835A
Other languages
English (en)
Inventor
Gerald L Chrisope
Original Assignee
Gynelogix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gynelogix Inc filed Critical Gynelogix Inc
Publication of NZ513835A publication Critical patent/NZ513835A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
NZ513835A 1997-04-11 1998-04-10 Methods for using vaginal lactobacillus NZ513835A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/834,649 US6093394A (en) 1997-04-11 1997-04-11 Vaginal lactobacillus medicant

Publications (1)

Publication Number Publication Date
NZ513835A true NZ513835A (en) 2001-09-28

Family

ID=25267456

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ513835A NZ513835A (en) 1997-04-11 1998-04-10 Methods for using vaginal lactobacillus
NZ500788A NZ500788A (en) 1997-04-11 1998-04-10 Vaginal lactobacillus medicant

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ500788A NZ500788A (en) 1997-04-11 1998-04-10 Vaginal lactobacillus medicant

Country Status (12)

Country Link
US (3) US6093394A (https=)
EP (1) EP1011721B1 (https=)
JP (2) JP2001523231A (https=)
KR (1) KR20010006273A (https=)
CN (1) CN1194758C (https=)
AT (1) ATE400281T1 (https=)
AU (1) AU732630B2 (https=)
BR (1) BR9808520A (https=)
CA (1) CA2285947C (https=)
DE (1) DE69839699D1 (https=)
NZ (2) NZ513835A (https=)
WO (1) WO1998046261A1 (https=)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
GB9916790D0 (en) * 1999-07-16 1999-09-22 Health Lab Service Board Storage of microorganisms,cells and tissue
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
AU2003276822A1 (en) * 2002-03-08 2004-02-02 Osel, Inc. Lactobacilli expressing biologically active polypeptides and uses thereof
DK1485463T3 (da) * 2002-03-21 2008-11-10 Bifodan As Lactobacillus stamme
KR100993562B1 (ko) 2002-03-21 2010-11-11 비포단 에이/에스 락토바실러스 균주
WO2003082306A1 (en) * 2002-03-28 2003-10-09 Gregor Reid Lactobacillus iners for the enhancement of urogenital health
JP2004067599A (ja) * 2002-08-07 2004-03-04 Kunihiko Tominaga 腟内洗浄剤
AT413334B (de) * 2002-12-23 2006-02-15 Belihart Josephine Feste darreichungsformen mit lebenden milchsäurebakterien
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
US20050095660A1 (en) * 2003-10-31 2005-05-05 Unibio, S.R.I. Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women
SI1506781T1 (https=) * 2003-11-03 2005-08-31 Volkmann Peter Hansen
GB2408750B (en) * 2003-12-02 2008-12-10 Arthur A Codd Preservation of biological material
WO2005085287A1 (en) * 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
CA2572939C (en) * 2004-07-23 2011-04-26 Stephen M. Renzin Mini pad for reducing inflammation of the vulva and method of making the same
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
WO2006045474A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
US20060217446A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating trichomonas vaginitis
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) * 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
EP1919446A4 (en) * 2005-08-04 2009-01-14 Femaceuticals Llc METHOD OF TREATING SKIN IRRITATION SUCH AS ERITREA FESSIER OF INFANTS AND OTHERS
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
EP1965839B1 (en) 2005-12-22 2012-07-25 SCA Hygiene Products AB Absorbent article
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
CN101557838A (zh) * 2006-11-17 2009-10-14 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
WO2008060198A1 (en) 2006-11-17 2008-05-22 Sca Hygiene Products Ab Lactobacillus fermentum ess-1, dsm17851 and its use for the treatment and/or prevention of candidiasis and urinary tracrinfections
US9283297B2 (en) 2006-11-17 2016-03-15 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
US20110066137A1 (en) * 2007-12-18 2011-03-17 Osel, Inc. Applicator for applying powder formulations and uses thereof
US8642029B2 (en) 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
ITMI20080949A1 (it) * 2008-05-22 2009-11-23 Sinclair Pharma Srl Nuovo ceppo del genere lactobacillus e formulazioni farmaceutiche topiche che lo contengono
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
US8445226B2 (en) * 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
IL208820A0 (en) 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
TWI401086B (zh) * 2010-07-20 2013-07-11 Univ China Medical 胚芽乳酸桿菌及其用途
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
CZ2010933A3 (cs) * 2010-12-15 2011-08-31 Valosun A.S. Probiotické kmeny Lactobacillus fermentum 16A/1 a Lactobacillus crispatus 13A a jejich využití k vaginální aplikaci
JP2015501635A (ja) * 2011-11-10 2015-01-19 ジェネラル ミルズ インコーポレーティッド 桿状菌の生存能力を高める手段及び方法
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9987222B2 (en) 2012-01-31 2018-06-05 Biosoma B.V. Method for administration of a probiotic
EA201590008A1 (ru) 2012-06-13 2015-05-29 Ивофем, Инк. Композиции и способы повышения эффективности бактерицидных средств контрацепции
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CN102716325A (zh) * 2012-06-28 2012-10-10 刘倩 一种治疗慢性盆腔炎的中药制剂
FR2992973B1 (fr) 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
FR2992861B1 (fr) 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103911308A (zh) * 2013-01-05 2014-07-09 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
SG11201603346VA (en) 2013-11-08 2016-05-30 Suzhou Osel Bio Pharm Co Ltd Lactobacillus crispatus and application thereof
CN104178437B (zh) * 2013-11-08 2016-08-24 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇科疾病中的应用
JP2017501227A (ja) 2013-12-19 2017-01-12 エヴォフェム，インク． アルギン酸をベースとする抗菌性化合物を使用して炎症と疾患を阻害するための組成物及び方法
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
CN104293718B (zh) * 2014-10-11 2017-01-18 中国科学院微生物研究所 一株詹氏乳杆菌及其应用
KR101980252B1 (ko) 2015-05-26 2019-05-21 (주)투라인스 질증 치료용 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
FR3048361B1 (fr) 2016-03-01 2020-12-18 Biose Compositions pour le traitement des candidoses
KR101957211B1 (ko) * 2016-03-21 2019-03-13 한국생명공학연구원 조산 및 질염 원인균에 대한 항균 활성, 성병 원인 바이러스에 대한 항바이러스 활성 및 질내 부착능이 우수한 락토바실러스 속 균주 및 이의 용도
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
CA3030408A1 (en) * 2016-07-11 2018-01-18 Hennepin Life Sciences, Llc Compositions for sexually transmitted diseases
CN106176821A (zh) * 2016-08-31 2016-12-07 汪金小 一种微生态阴道菌剂及其制备方法和应用
JP7111699B2 (ja) * 2016-09-16 2022-08-02 デュポン ニュートリション バイオサイエンシーズ エーピーエス 細菌
US11419835B2 (en) 2016-10-04 2022-08-23 Evofem, Inc. Method of treatment and prevention of bacterial vaginosis
MX2019006193A (es) 2016-11-30 2019-08-21 Probioswiss Ag Formulacion para dispositivo medico urogenital a base de composiciones bioquimicas adecuadas para la estabilizacion de la acidez y el estado redox del fluido vaginal.
KR102048690B1 (ko) * 2016-12-16 2019-11-26 (주)휴온스 안정성이 증진된 유산균 및 이의 제조방법
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
WO2018183685A1 (en) 2017-03-29 2018-10-04 President And Fellows Of Harvard College Methods of regulating gene expression in a cell
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
CN107299065B (zh) * 2017-06-20 2020-02-14 广东强基药业有限公司 一种植物乳杆菌及其用于制备阴道抑菌药物的应用
WO2019010282A1 (en) 2017-07-07 2019-01-10 Osel, Inc. STABILIZED FORMULATIONS WITH HIGH POWER OF LACTOBACILLUS VAGINAL
EP3648779A4 (en) * 2017-07-07 2021-03-17 Osel, Inc. USING VAGINAL LACTOBACILLI TO IMPROVE THE SUCCESS RATE OF IN VITRO FERTILIZATION
KR20200077534A (ko) 2017-10-20 2020-06-30 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 이종 단백질 생성을 위한 인공 분비 펩티드
CN107815432B (zh) * 2017-12-07 2021-09-28 广州柏芳生物科技有限公司 一种人用灭活乳酸菌制剂及其用途
EP3843701B1 (en) * 2018-08-30 2024-02-21 Osel, Inc. Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
GB201816425D0 (en) * 2018-10-09 2018-11-28 Tervisetehnoloogiate Arenduskeskus As Probiotics
KR102053744B1 (ko) * 2018-11-27 2019-12-09 한국생명공학연구원 질염 원인균에 대한 항균 활성 및 질내 부착능이 우수한 락토바실러스 속 균주 및 이의 용도
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP4294417A1 (en) * 2021-02-19 2023-12-27 Imperial College Innovations Limited Lactobacillus crispatus composition for use in pregnant subjects
TW202334391A (zh) * 2021-10-26 2023-09-01 南韓商日東製藥股份有限公司 多個捲曲乳桿菌菌株和含有該多個菌株的用於預防或治療陰道炎的組合物
KR102683248B1 (ko) 2021-11-10 2024-07-10 장효영 질염 예방 및 치료를 위한 주입형 질 유산균 조성물
CN115337256A (zh) * 2022-06-24 2022-11-15 郑州伊品医药科技有限公司 一种含有益生菌的阴道栓塞及胶囊的制备方法
CN116355805B (zh) * 2023-04-11 2025-07-25 吉林大学 一株猪源广谱抑菌的阴道乳杆菌及其应用
CN118308277B (zh) * 2024-06-12 2024-09-13 广州莱可福生物科技有限公司 一种卷曲乳杆菌及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127268A (https=) * 1970-01-12 1900-01-01
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5953425A (ja) * 1982-09-22 1984-03-28 Meiji Milk Prod Co Ltd 「ちつ」
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4956177A (en) * 1985-11-04 1990-09-11 Microlife Technics, Inc. Method for inhibiting fungi
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SU1364341A1 (ru) * 1986-09-18 1988-01-07 Центральный научно-исследовательский институт вакцин и сывороток им.И.И.Мечникова Способ получени бифидумбактерина
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
US4765978A (en) * 1986-12-16 1988-08-23 Schering Corporation Novel vaginal suppository
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US5296221A (en) * 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
JPH0421633A (ja) * 1990-05-17 1992-01-24 Saikon Medics:Kk 生体下口腔内有用微生物叢の維持管理法および維持管理組成物
JP3014148B2 (ja) * 1991-01-17 2000-02-28 株式会社ヤクルト本社 悪性腫瘍再発抑制剤
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
DE4109036C1 (https=) * 1991-03-15 1992-08-13 Eckhard Dr. 1000 Berlin De Lauer
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
FR2746109B1 (fr) * 1996-03-12 1998-04-17 Rhone Poulenc Rorer Sa Milieu pour la conservation de materiel biologique
EP0927023B1 (en) * 1996-09-13 2004-11-03 Clemson University Composition for treating acne
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
ATE207755T1 (de) 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen

Also Published As

Publication number Publication date
DE69839699D1 (de) 2008-08-21
AU7359098A (en) 1998-11-11
BR9808520A (pt) 2002-01-15
KR20010006273A (ko) 2001-01-26
EP1011721A1 (en) 2000-06-28
NZ500788A (en) 2003-04-29
CN1259874A (zh) 2000-07-12
US6093394A (en) 2000-07-25
US20020090365A1 (en) 2002-07-11
EP1011721A4 (en) 2003-09-24
AU732630B2 (en) 2001-04-26
ATE400281T1 (de) 2008-07-15
CA2285947C (en) 2012-02-28
US6468526B2 (en) 2002-10-22
JP2010031031A (ja) 2010-02-12
EP1011721B1 (en) 2008-07-09
CN1194758C (zh) 2005-03-30
JP2001523231A (ja) 2001-11-20
US6372209B1 (en) 2002-04-16
WO1998046261A1 (en) 1998-10-22
CA2285947A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
NZ513835A (en) Methods for using vaginal lactobacillus
CA2254548A1 (en) Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
NZ335521A (en) Bacillus thuringiensis strain AQ52 for controlling antimicrobial activity against fungi and bacteria
UA26430C2 (uk) Штам молочhокислих бактерій lастовасіllus асіdорhіlus як засіб проти діареї та композиція проти діареї
CA2271930A1 (en) Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
AU1223099A (en) Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
NZ335084A (en) Use of Rhodococcus and Nocardia bacterium species in degrading zearalenone in plants
AU6564794A (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
SE9102238D0 (sv) Tarmkoloniserande laktobaciller
DK0506817T3 (da) Farmaceutisk præparat til kontrol med patogene intestinale bakterier
ES2162243T3 (es) Microorganismos y su utilizacion en el tratamiento de alimentos para animales y ensilado.
GB8701234D0 (en) Strain of microorganism
MY109486A (en) Method employing type ii endoglycosidase
PL340370A1 (en) Pesticide against pathogenic micro-organism attacking plants
AU2001290302A1 (en) Bone metabolism improving agent
EP0369198A3 (en) Forage preservation
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
WO2001040280A3 (en) Composition and method for treating a microbial infection
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
EP1060745A3 (en) A composition and method for treating bacterial infection
WO1998031786A3 (en) Novel microorganisms
UA27008C2 (uk) Спосіб обробки призhачеhого для пророщуваhhя hасіhhєвого матеріалу
AU1665900A (en) Foulbrood treatments
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
IT1316985B1 (it) Terreno di coltura per la coltura di lactobacillus clearans e metodoper la conservazione di detto ceppo batterico.